Nation’s Largest Generic Drug Maker To Pay $450 Million To Resolve Kickback, Price-Fixing Claims Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. (collectively, Teva) have agreed to pay $450 million to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA), according to the U.S. Department of Justice (DOJ). Teva is an Israeli company, with U.S. headquarters in Parsippany, New Jersey, and is the largest generic drug manufacturer in the United States, according to the DOJ. The settlement amount was based on Teva’s ability to pay, the DOJ said. As Chase Smith details below, via… — Continue at ZeroHedge News : Read More
Home » Nation’s Largest Generic Drug Maker To Pay $450 Million To Resolve Kickback, Price-Fixing Claims – Tyler Durden